Luckwel Pharmaceuticals Inc. LWEL OTC

Other OTC • Financial Services • Shell Companies • US • USD

SharesGrow Score

22/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Luckwel Pharmaceuticals Inc. (LWEL) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 20/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

22/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

→ Health

MOAT

46/100

→ Income

GROWTH

40/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — LWEL

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$0.00

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2013	$0.00	$0.00	$-225.00	-
2014	$-0.02	$0.00	$-225K	-
2015	$-0.03	$950.00	$-264.16K	-27805.8%
2016	$-0.03	$44.00	$-420.73K	-956200%
2017	$-0.03	$-1.7K	$-511K	-
2018	$-0.03	$295.00	$-537K	-182033.9%
2019	$0.00	$5.00	$-622.53K	-12450520%
2020	$0.00	$0.00	$-536K	-
2021	$0.00	$0.00	$-436K	-